Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

Clinical trial NCT05750589 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05750589
Sponsor: iRenix Medical, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Retinal Disease

Start date: 2026-09-01
Primary completion: 2027-01-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.